Collateral for a security interest recorded Nov 29, 2023 (Fish & Richardson PC).
Term ends Jun 12, 2033 · High confidence
20-year base term ends Jun 12, 2033
Held by Quiapeg Pharmaceuticals AB
Filed Feb 11, 2019 as application 16/272,930 · Granted May 19, 2020
Base term, 20 years from filing
Today
2013
2033
Clock starts
Jun 12, 2013
Jun 12, 2013
Term ends
Jun 12, 2033
Jun 12, 2033
Granted
May 19, 2020
May 19, 2020
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 12, 2013, when application 13/916,251, the earliest non-provisional in its chain, was filed (this one was filed Feb 11, 2019) | Jun 12, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 12, 2033 | High confidence |
This family
| US 9,220,789 | In force Jun 2033 | Jun 2033 |
| US 9,849,187 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 10,207,007 | In force Jun 2033 | Jun 2033 |
| US 10,653,788 | this patent Jun 2033 | Jun 2033 |
| US 10,973,921 | Lapsed on the fee record Apr 2025 | Apr 2025 |
| US 11,382,984 | Lapsed on the fee record Jul 2026 | Jul 2026 |
| US 11,723,981 | In force Jun 2033 | Jun 2033 |
| Application 18/202,880 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 9, 2019 Reel 49702, frame 91 | Kwiatkowski, Marek | Quiapeg AB | Assignment of Assignor's Interest |
| Jul 9, 2019 Reel 49706, frame 416 | Quiapeg AB | Quiapeg Pharmaceuticals AB | Change of Name |
| Mar 31, 2020 Reel 52276, frame 618 | Kwiatkowski, Marek | Quiapeg AB | Assignment of Assignor's Interest |
| Mar 31, 2020 Reel 52277, frame 25 | Kwiatkowski, Marek | Quiapeg Pharmaceuticals AB | Assignment of Assignor's Interest |
| Mar 31, 2020 Reel 52279, frame 748 | Quiapeg AB | Quiapeg Pharmaceuticals AB | Change of Name |
| Nov 29, 2023 Reel 65714, frame 116 | Quiapeg AB | Fish & Richardson PC | Lien |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2033
Term ends Jun 12, 2033. Maintenance fees still fall due before then
Citations
6
later US patents cite this one
That is above the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.